Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Cash from Investing Activities (2020 - 2023)

Cullinan Therapeutics has reported Cash from Investing Activities over the past 4 years, most recently at $51.5 million for Q4 2023.

  • Quarterly results put Cash from Investing Activities at $51.5 million for Q4 2023, up 279.9% from a year ago — trailing twelve months through Dec 2023 was $35.8 million (down 85.62% YoY), and the annual figure for FY2025 was $180.0 million, up 232.04%.
  • Cash from Investing Activities for Q4 2023 was $51.5 million at Cullinan Therapeutics, up from -$43.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for CGEM hit a ceiling of $300.9 million in Q2 2022 and a floor of -$154.6 million in Q2 2021.
  • Median Cash from Investing Activities over the past 4 years was -$8.9 million (2020), compared with a mean of -$3.4 million.
  • Biggest five-year swings in Cash from Investing Activities: crashed 1391.4% in 2021 and later skyrocketed 294.61% in 2022.
  • Cullinan Therapeutics' Cash from Investing Activities stood at $11.4 million in 2020, then crashed by 238.65% to -$15.9 million in 2021, then crashed by 80.37% to -$28.6 million in 2022, then skyrocketed by 279.9% to $51.5 million in 2023.
  • The last three reported values for Cash from Investing Activities were $51.5 million (Q4 2023), -$43.0 million (Q3 2023), and $12.1 million (Q2 2023) per Business Quant data.